The c-Myc and TBX3 oncoproteins are overexpressed in several sarcoma subtypes including chondrosarcoma, liposarcoma and rhabdomyosarcoma where they exert tumorigenic effects (1, 15, 17). This evidence concerns the gene MYC and rhabdomyosarcoma.